Power Law company profile

ARMO Bio Sciences

Biotech & Life Sciences · Palo Alto, United States · Founded 2013 · IPO 2018 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.60B

Market cap · 2026

Investors

12 investors on ARMO Bio Sciences's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage

OrbiMed

Kleiner Perkins

DAG Ventures

Series B+ 9 investors entered at this stage

Qiming Venture Partners

Qiming Venture Partners USA

Sequoia

+ND Capital

Quan Capital

Industrial Investors Group

Decheng Capital

RTW Investments

Celgene

Patent intelligence

$11M patent portfolio · 9 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$11M

0.67% of market cap · 20.8× smaller than top peer Ganymed Pharmaceuticals ($223M)

9 active patent families

Where ARMO Bio Sciences innovates DiseaseInterleukinWhite blood cellDisease injuryInterleukin 10

Below peer median on Legal, Strategic, Economic, Technology

Quality vs same-sector peers

ARMO Bio Sciences on the five Patsnap quality dimensions

ARMO Bio Sciences in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where ARMO Bio Sciences concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across ARMO Bio Sciences and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See ARMO Bio Sciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo